Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 323 clinical trials
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma

In this study, a score based on glycosaminoglycan (GAG) profiling in subjects with suspicion of renal cell carcinoma (RCC) is hypothesized to distinguish malignant masses when early actionable

nephrectomy
carcinoma
  • 8 views
  • 22 Jan, 2021
  • 1 location
Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Pancreatic metastases are a rare entity. In cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection.

  • 0 views
  • 26 Jan, 2021
  • 2 locations
Nivolumab in mRCC Patients: Treg Function T-cell Access and NK Interactions to Predict and Improve Efficacy

The project aims to identify Nivolumab predictive biomarkers in metastatic renal cancer patients through functional evaluation of peripheral Tregs and NKs. Moreover the efficacy of new CXCR4 antagonists (PCT/IB2011/000120/ EP2528936B1/ US2013/0079292A1) will be ex vivo evaluated in modulating Tregs and NKs function

everolimus
carcinoma
nivolumab
kidney cancer
axitinib
  • 0 views
  • 25 Jan, 2021
  • 1 location
Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

of this study is to acquire tumor and blood samples from up to 40 patients with renal cell carcinoma (RCC) malignancies who respond to ICI therapy. T cells will be isolated from these samples and the

  • 0 views
  • 25 Apr, 2021
  • 1 location
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations

This study aims to observe the difference between NMAP (nicotinamide metabolism associated protein) serum levels in primary diagnosed renal cancer patients and non-renal cancer patient controls, plot the ROC curve and establish appropriate cut-off values.

  • 0 views
  • 26 Jan, 2021
  • 1 location
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative

There are limited data regarding the biology and treatment of TFE Renal Cell Carcinoma (TFE RCC). This project provides the infrastructure for acquisition of biological specimens, imaging, and

cancer
carcinoma
  • 4 views
  • 24 Jan, 2021
  • 1 location
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma

The purpose of the study is to identify bacterial and fungal microbiome associated with calcium oxalate (CO) urolithiasis and renal cell carcinoma (RCC).

  • 0 views
  • 20 Mar, 2021
  • 1 location
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

This study is a survey in Japan of Cabozantinib tablets used to treat people with a type of kidney cancer called renal cell carcinoma. The study sponsor will not be involved in how the

  • 0 views
  • 30 Apr, 2021
  • 1 location
VETC Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

found in renal cell carcinoma, adrenal gland pheochromocytoma, thyroid follicular carcinoma and alveolar soft part sarcoma (ASPS) and associated to prognosis. Moreover, the distinction between benign

  • 0 views
  • 17 Feb, 2021
  • 1 location
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

This is a comparative study using resected/ biopsied tumors samples collected from renal cell carcinoma and urothelial carcinoma patients who underwent surgical removal of lesions, followed by

carcinoma
transitional cell carcinoma
metastasis
metastasectomy
immune checkpoint inhibitor
  • 0 views
  • 26 Jan, 2021
  • 1 location